Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Calcitriol - Roche

Drug Profile

Calcitriol - Roche

Alternative Names: Dihydroxycholecalciferol - Roche; Dihydroxyvitamin D3 - Roche; RO 215535; Rocaltrol

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche
  • Developer Chugai Pharmaceutical; Kirin Holdings Company; Roche; Roche Canada; Roche Wien
  • Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
  • Mechanism of Action Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Calcium metabolism disorders; Hypocalcaemia; Hypoparathyroidism; Hypophosphataemia; Osteodystrophy; Osteomalacia; Postmenopausal osteoporosis; Rickets; Secondary hyperparathyroidism; Vitamin D deficiency
  • No development reported Cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Cancer in USA (SC)
  • 15 Mar 2016 Biomarkers information updated
  • 16 Jun 2008 Fontus Pharmaceuticals acquires Calcitriol from Roche
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top